Company / Gross Margin
INTERPACE BIOSCIENCES, INC. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
62.3%
FY2025
5-year range
62.3% / 321.1%
FY2021-FY2025
Trend
-2.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has declined for 3 consecutive years, from 321.1% in FY2022 to 62.3% in FY2025.
Based on SEC 10-K filings.
62.3% in FY2025 with a 5-year CAGR of +29.2%.
Declined from 64.5% to 62.3% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -258.8pp
- 5-Year Change
- +29.2pp
- 10-Year Change
- -
Key checks
Key Insights
- INTERPACE BIOSCIENCES, INC.'s gross margin has declined for 3 consecutive years.
- In FY2025, gross margin decreased 2.3% year-over-year.
- Peak gross margin was recorded in FY2022.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.84 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 62.3% | -2.3% |
| FY2024 | 63.8% | -1.2% |
| FY2023 | 64.5% | -79.9% |
| FY2022 | 321.1% | +40.0% |
| FY2021 | 229.4% | +593.0% |
| FY2020 | 33.1% | -3.8% |
| FY2019 | 34.4% | -35.6% |
| FY2018 | 53.4% | -0.5% |
| FY2017 | 53.7% | +9.1% |
| FY2016 | 49.3% | +84.2% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026